Navigation Links
Four Pharmaceutical Companies Pay $124 Million for Submission of False Claims to Medicaid
Date:10/19/2009

WASHINGTON, Oct. 19 /PRNewswire-USNewswire/ -- Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceutical have entered into settlement agreements for a total of $124 million to resolve claims that they violated the False Claims Act by failing to pay appropriate rebates to state Medicaid programs for drugs paid for by those programs, the Justice Department announced today.

The Medicaid Prescription Drug Rebate Program was enacted by Congress in 1990 out of concern for the costs that Medicaid was paying for outpatient drugs. By agreeing to participate in the Medicaid Rebate Program and signing these rebate agreements, the four companies agreed to pay quarterly rebates to Medicaid that were based upon the amount of money that health care program paid for each company's drugs. The precise amount of a rebate is determined in part by whether a drug is considered an "innovator" drug or a "non-innovator" drug. The rebate that must be paid for innovator drugs is higher than the rebate for non-innovator drugs.

Each of the companies agreed to pay a settlement to resolve allegations that it had sold innovator drugs that were manufactured by other companies and had classified those drugs as non-innovator drugs for Medicaid rebate purposes. As a result of the improper classification of these drugs, the companies underpaid their rebate obligations under the Medicaid Rebate Program.

Mylan and UDL agreed to pay $118 million to resolve allegations that they underpaid their rebate obligations with respect to several Mylan drugs (nifedipine extended release tablets, flecainide acetate, selegiline HCL, Orphenadrine Citrate Aspirin and Caffeine tablets, Triamterene/Hydrochlorothiazide, Propoxyphene HCL, Propoxyphene HCL/Aspirin/Caffeine, Prophyxphene Napsylate/Acetaminophen, Ibuprofen tablets, Bumetanide, Cephalexin and Cefactor) and several UDL drugs (nifedipine extended release tablets, selegiline HC
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... JERUSALEM , May 17, 2013 ... a developer of oral drug delivery systems, announced today ... has cleared the Company,s Investigational New Drug application(IND) for ... very pleased to have the FDA clearance to proceed," ... Oramed. "The upcoming trial is a major milestone for ...
(Date:5/17/2013)... Mass. , May 17, 2013  Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...
(Date:5/16/2013)... and MECHELEN, Belgium , May 17, ... (NYSE: ABBV ) announced today an extension ... disease.  Galapagos will fund and complete a Phase 2 ... rapid progression into Phase 3.  Upon successful completion of ... Galapagos $50 million.  The terms of the collaboration extension ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... Solutions, Inc., a leading provider of scientific information and analytics ... Rep. Ben Quayle ( R-AZ, 3 rd ... team to discuss the company,s role in the delivery of ... on Camelback Road in Phoenix to learn more about the ...
... 2011 The UNT System Board of Regents approved a ... Texas legislative session. As part of the three-way partnership among ... College of Pharmacy students will earn a Doctor of Pharmacy ... classes on the UNT Health Science Center campus at Fort ...
Cached Medicine Technology:Congressman Quayle Talks With Wolters Kluwer Pharma Solutions About Importance of Health Information 2Congressman Quayle Talks With Wolters Kluwer Pharma Solutions About Importance of Health Information 3UNT Regents Approve New College of Pharmacy 2
(Date:5/18/2013)... There are significant cost and risk factors ... or treat gastrointestinal problems, according to research presented ... study by New York Presbyterian Hospital and Weill-Cornell ... substantially reduce the cost and risk of managing ... to affect nearly 25 percent of adults, researchers ...
(Date:5/18/2013)... In a May 14, 2013 article entitled ... Discovering Cancer Gene,” Fox News reported the movie star ... she carried a gene that doctors estimated gave her ... 50 percent risk of ovarian cancer (go to: goo.gl/5JHBP). ... 2013 with a blog post entitled “A Patient’s Journey: ...
(Date:5/18/2013)... Orlando, FL (May 18, 2013) A ground-breaking ... colorectal care, according to research presented today at ... optimizing the minimal withdrawal time for colonoscopies and ... , During colonoscopy, doctors use a device called ... test for colorectal cancer allows a doctor to ...
(Date:5/18/2013)... New York (PRWEB) May 18, 2013 ... pelvic mesh products continue to move forward in a ... Court, Bernstein Liebhard LLP reports. According to a notice ... in the Ethicon pelvic mesh litigation will be held ... 2,755 complaints have been filed in the proceeding on ...
(Date:5/18/2013)... By Serena Gordon HealthDay Reporter , , FRIDAY, May ... college students sometimes binge drink, but new research shows that ... alcohol on a weekly basis than are college men. ... of alcohol that,s considered safe on a weekly basis is ... drinks for women versus 14 for men. But, there,s good ...
Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3
... in California Fires Response Effort, TALLAHASSEE, Fla., Oct. ... the California wildfires, the Capital Area Chapter of,the American ... effort. "Whether across the country or around the ... prepared to respond to tragedy and in this,case, to ...
... 25 As of 1:00 p.m. PST,today, 120 ... Village retirement campus in Spring Valley. Emergency service,authorities ... and residents were transported to the campus from ... The residents were evacuated late,Monday night. Campus ...
... than doubled the odds, study found , , THURSDAY, Oct. 25 ... more than double their risk of needing subsequent surgery for ... true regardless of what type of surgical technique was used ... is published in the Oct. 27 issue of The ...
... Excellence in Ethical, Legal and Social Implications (ELSI) Research ... of Medicine, a collaboration with the Schools of Nursing ... Annenberg School for Communication. , The Penn Center ... will receive over $5 million over the next five ...
... in mice, study says , , THURSDAY, Oct. 25 (HealthDay ... ability to reduce Alzheimer,s disease-like symptoms in mice, researchers ... Diovan, emerged from a screening program that started with ... Giulio Maria Pasinetti, a professor of psychiatry and neurosciences ...
... BME (BioMedical Enterprises, Inc.),today announced that Andrew K. ... was elected to BME,s Board of Directors. ... in his leadership as,Medical Director of BME by ... relationships and corporate,reputation. His informal advice to the ...
Cached Medicine News:Health News:Capital Area Chapter Deploys Volunteers to California 2Health News:Hysterectomy May Boost Incontinence Risk 2Health News:Hysterectomy May Boost Incontinence Risk 3Health News:Penn wins $5M to start center for ethical, legal and social implications research 2Health News:Penn wins $5M to start center for ethical, legal and social implications research 3Health News:Blood Pressure Drug Might Work Against Alzheimer's 2
... Korchek Technologies CareChek Rx ... barcode technology, Windows CE ... integrated scanners (to perform ... the bedside) and an ...
... provides care management tools that support the ... as vital signs and I&O information at ... use on-line flow sheets. This design supports ... in the hall, or at the nursing ...
For superior bar code scanning performance with maximum user comfort at a highly attractive price, the LS 4000i Scanner Series from Symbol Technologies establishes an award-winning standard of excell...
... polyester, latex-free, thermal transfer wristband for ... Prints images that resist smears and ... mild cleaners, and blood. A time-tested ... and patron management applications. A tamper-evident ...
Medicine Products: